|
Professor Mark W. Grinstaff
William Fairfield Warren Distinguished Professor Distinguished Professor of Translational Research Professor of Biomedical Engineering, Chemistry, Materials Science and Engineering, and Medicine email: mgrin@bu.edu twitter: @ Grinstaff |
|
Mark W. Grinstaff is the Director of the NIH T32 Program in Translational Research in Biomaterials (TRB) and the Nanotechnology Innovation Center (BUnano) at Boston University. Mark received his Ph.D. from the University of Illinois under the mentorship of Professor Kenneth S. Suslick and was an NIH postdoctoral fellow at the California Institute of Technology with Professor Harry B. Gray. Mark's awards include the ACS Nobel Laureate Signature Award, NSF Career Award, Pew Scholar in the Biomedical Sciences, Clemson Award for Applied Research, Camille Dreyfus Teacher- Scholar, Alfred P. Sloan Research Fellowship, and the Edward M. Kennedy Award for Health Care Innovation.
He is a Fellow of the American Institute for Medical and Biomedical Engineering, a Fellow of the Royal Chemical Society, a Fellow of the American Institute of Chemists, a Fellow of the Biomedical Engineering Society, a Fellow of the Royal Society of Medicine, a Fellow of the International Academy of Medical and Biological Engineering, and a Fellow of the American Association for the Advancement of Science, and a Founding Fellow of the National Academy of Inventors.
Mark is an author or co-author on more than 375 peer-reviewed manuscripts, given more than 350 oral presentations, and an inventor or co- inventor on more than 200 issued patents or pending applications. He is a co-founder of several companies that are commercializing his ideas, and he has several products being sold and used in the clinic. His current research activities involve the synthesis of new macromolecules and biomaterials, self-assembly chemistry, imaging contrast agents, drug delivery, and wound repair.
He is a Fellow of the American Institute for Medical and Biomedical Engineering, a Fellow of the Royal Chemical Society, a Fellow of the American Institute of Chemists, a Fellow of the Biomedical Engineering Society, a Fellow of the Royal Society of Medicine, a Fellow of the International Academy of Medical and Biological Engineering, and a Fellow of the American Association for the Advancement of Science, and a Founding Fellow of the National Academy of Inventors.
Mark is an author or co-author on more than 375 peer-reviewed manuscripts, given more than 350 oral presentations, and an inventor or co- inventor on more than 200 issued patents or pending applications. He is a co-founder of several companies that are commercializing his ideas, and he has several products being sold and used in the clinic. His current research activities involve the synthesis of new macromolecules and biomaterials, self-assembly chemistry, imaging contrast agents, drug delivery, and wound repair.
|
|
|
|
|
|
|
|
|